Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer ... - MarketWatch (press release)
Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer... MarketWatch (press release) "We believe ERG testing by IHC and ISH will play an important role in novel diagnostic, prognostic, and predictive tests for prostate cancer," says Mara G. Aspinall, President of Ventana Medical Systems, Inc. "This license gives us a unique position ...
U.S. House of Representatives' Armed Services Committee And Appropriations ... - MarketWatch (press release)
U.S. House of Representatives' Armed Services Committee And Appropriations ... MarketWatch (press release) The House Armed Services Committee Report accompanying the National Defense Authorization Act for fiscal year 2013 (HR 4310) recognized that "in spite of the magnitude of the prostate cancer epidemic in the military and civilian populations, ...
Prostate Cancer Survivor Talks About Diagnosis For Mayor Jones - WCHS
Prostate Cancer Survivor Talks About Diagnosis For Mayor Jones WCHS A former West Virginia governor says the recent prostate cancer diagnosis for Charleston Mayor Danny Jones should serve as a reminder for everyone about the importance of regular screenings. "The more people who can get examined, the better.
Researchers in Galway battle against cancer on many fronts Irish Times INNOVATION PROFILE: Cancer research at NUI Galway: FOR REASONS which are still a matter of conjecture and research, the people in the west of Ireland have significantly higher rates of breast and prostate cancer than the rest of the Irish population.
Treatment of early stage prostate cancer can also result in improved QOL for ... - News-Medical.net
Treatment of early stage prostate cancer can also result in improved QOL for ... News-Medical.net Treatment of early stage prostate cancer can also result in improved quality of life for a subgroup of men who suffer from lower urinary tract symptoms (LUTS), according to an abstract of a Beth Israel Deaconess Medical Center-led study presented to ...
What our clients and candidates are saying about us: It isn’t often a potential employer responds, let alone with added assistance. It is a refreshing break from tradition, and appreciated. - Carla
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.